Oncologix Tech, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OCLG research report →
Companywww.oclghealth.com
Oncologix Tech, Inc. , a diversified medical holding company, provides health care services in the United States. It offers personal home care services, including daily living assistance, companionship, and homemaker services, as well as Alzheimer's care, home care resource planning, and medical care coordination services.
- CEO
- Michael A. Kramarz
- IPO
- 2013
- Employees
- 191
- HQ
- Lafayette, LA, US
Price Chart
Valuation
- Market Cap
- $73.66K
- P/E
- -0.03
- P/S
- 0.03
- P/B
- 0.04
- EV/EBITDA
- -0.07
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 20.05%
- Op Margin
- -30.35%
- Net Margin
- -83.19%
- ROE
- 94.77%
- ROIC
- 0.00%
Growth & Income
- Revenue
- $2.85M · 0.00%
- Net Income
- $-2,371,000 · 0.00%
- EPS
- $-0.00 · 0.00%
- Op Income
- $-865,000
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 9.58
- Avg Volume
- 210.04K
Get TickerSpark's AI analysis on OCLG
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 8, 13 | SILVERMAN ANTHONY | other | 1,024,164 |
| Feb 8, 13 | SILVERMAN ANTHONY | other | 1,024,164 |
| Feb 8, 13 | SILVERMAN ANTHONY | other | 1,024,164 |
| Jan 26, 12 | SILVERMAN ANTHONY | sell | 250,000 |
| Jan 26, 12 | SILVERMAN ANTHONY | sell | 250,000 |
| Dec 26, 11 | SILVERMAN ANTHONY | other | 250,000 |
| Oct 6, 11 | SILVERMAN ANTHONY | other | 1,778,193 |
| Oct 6, 11 | SILVERMAN ANTHONY | other | 1,778,193 |
| Oct 6, 11 | SILVERMAN ANTHONY | other | 1,778,193 |
| Oct 6, 11 | SILVERMAN ANTHONY | other | 1,778,193 |
Our OCLG Coverage
We haven't published any research on OCLG yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate OCLG Report →